Prometheus Biosciences In... (RXDX)
NASDAQ: RXDX
· Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 10:00 PM
Prometheus Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
PE Ratio | -31.15 | -30.47 | -16.81 | -8.31 | -11.49 | -12.17 | -8.42 | -12.54 | -12.02 | -19.79 | -24.56 |
PEG Ratio | 7.01 | -13.41 | -4.76 | -2.27 | -9.31 | -0.77 | -0.2 | -0.43 | -0.64 | -0.86 | 1.52 |
PS Ratio | 4.61K | 7.24K | 2.51K | 872.99 | 375.83 | 1.48K | 915.60 | 2.92K | 882.02 | 1.47K | 1.9K |
PB Ratio | 7.30 | 6.99 | 10.46 | 5.78 | 7.12 | 6.54 | 3.51 | 3.38 | 2.23 | -7 | n/a |
P/FCF Ratio | -127.1 | -113.87 | -99.74 | -37.26 | -48.54 | -68.8 | -53.11 | -169.05 | -34.75 | -128.86 | -149.04 |
P/OCF Ratio | -128.81 | -114.89 | -101.79 | -38.4 | -50.12 | -69.39 | -54.26 | -177.95 | -35.29 | -128.35 | -150.32 |
OCF/S Ratio | -35.79 | -62.98 | -24.69 | -22.73 | -7.5 | -21.39 | -16.88 | -16.43 | -24.99 | -11.48 | -12.65 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.13 | 0.08 | 0.07 | n/a | n/a | 0.03 | 0.02 | -0.08 | n/a |
Quick Ratio | 37.56 | 31.08 | 11.19 | 13.32 | 13.56 | 16.21 | 19.02 | 17.61 | 36.26 | 3.77 | n/a |
Current Ratio | 37.56 | 31.04 | 11.19 | 13.32 | 13.56 | 16.14 | 19.02 | 17.61 | 36.26 | 3.77 | n/a |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | n/a |
Interest Coverage | n/a | n/a | n/a | -105.82 | -1.07K | 17.39 | -2.06K | -99.19 | -18.57 | -13.44 | -20.51 |
Return on Equity | -0.06 | -0.06 | -0.16 | -0.17 | -0.15 | -0.13 | -0.1 | -0.07 | -0.05 | 0.09 | n/a |
Return on Assets | -0.05 | -0.05 | -0.12 | -0.14 | -0.13 | -0.12 | -0.09 | -0.06 | -0.04 | -0.14 | n/a |
Return on Invested Capital | -0.07 | -0.06 | -0.13 | -0.15 | -0.14 | -0.13 | -0.1 | -0.06 | -0.04 | -0.19 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | -36.99 | -59.36 | -37.36 | -26.26 | -8.17 | -30.49 | -27.17 | -58.28 | -18.35 | -18.62 | -19.35 |
Pretax Profit Margin | -36.99 | -59.36 | -38.51 | -26.51 | -8.18 | -28.85 | -27.17 | -58.28 | -18.35 | -19.89 | -21.8 |
Operating Profit Margin | -44.08 | -63.29 | -39.65 | -26.77 | -8.19 | -28.88 | -26.63 | -57.81 | -16.08 | -18.49 | -20.8 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -44.08 | -63.29 | -38.33 | -26.39 | -8.16 | -30.51 | -27.08 | -57.52 | -17.43 | -17.18 | -18.25 |